Showing 3,461 - 3,480 results of 10,572 for search '"Tumor"', query time: 0.11s Refine Results
  1. 3461

    SegChaNet: A Novel Model for Lung Cancer Segmentation in CT Scans by Mehmet Akif Cifci

    Published 2022-01-01
    “…Accurate lung tumor identification is crucial for radiation treatment planning. …”
    Get full text
    Article
  2. 3462

    PPAR𝛾, PTEN, and the Fight against Cancer by Rosemary E. Teresi, Kristin A. Waite

    Published 2008-01-01
    “…Activation of PPAR𝛾 through agonists increases functional PTEN protein levels that subsequently induces apoptosis and inhibits cellular growth, which suggests that PPAR𝛾 may be a tumor suppressor. Indeed, several in vivo studies have demonstrated that genetic alterations of PPAR𝛾 can promote tumor progression. …”
    Get full text
    Article
  3. 3463

    The Role of Targeted Therapy in Metastatic Renal Cell Carcinoma by Jaya Unnithan, Brian I. Rini

    Published 2007-01-01
    “…Renal cell carcinoma (RCC) is a highly vascular tumor in which a growing understanding of disease biology has been translated into clinically active systemic therapies. …”
    Get full text
    Article
  4. 3464

    Paraurethral Leiomyoma in a Postmenopausal Woman: First European Case by Susy Shim, Camilla Skovvang Borg, Huda Galib Majeed, Peter Humaidan

    Published 2015-01-01
    “…Transvaginal ultrasound and MRI confirmed the tumor and excision of the paraurethral tumor was carried out. …”
    Get full text
    Article
  5. 3465

    NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis by Shin Maeda

    Published 2010-01-01
    “…It seems that toll-like receptors (TLRs) as well as the nuclear factor (NF)-κB, and JNK pathways are critical regulators for the production of the cytokines associated with tumor promotion. The cross-talk between an inflammatory cell and a neoplastic cell, which is instigated by the activation of NF-κB and JNKs, is critical for tumor organization. …”
    Get full text
    Article
  6. 3466

    Rhabdomyosarcoma Orbita by Elfi Risalma Puteri, Ardizal Rahman

    Published 2019-09-01
    “…Rhabdomyosarcoma (RMS) merupakan tumor ganas pada jaringan lunak yang sering mengenai anak-anak. …”
    Get full text
    Article
  7. 3467

    Blasting neuroblastoma using optimal control of chemotherapy by Craig Collins, K. Renee Fister, Bethany Key, Mary Williams

    Published 2009-05-01
    “…Numericalsimulations are given to demonstrate the behavior of the tumor and the immune systemcomponents represented in the model.…”
    Get full text
    Article
  8. 3468

    New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma by Cong Luo, Xingxing Min, Danying Zhang

    Published 2025-01-01
    “…Osteosarcoma, a malignant bone tumor primarily affecting adolescents, is highly invasive with a poor prognosis. …”
    Get full text
    Article
  9. 3469

    Myofibroblastoma of the Breast: Literature Review and Case Report by Mario Metry, Mohamad Shaaban, Magdi Youssef, Michael Carr

    Published 2016-01-01
    “…Myofibroblastoma of the breast is a rare benign spindle cell tumor. The main aim of this study is to review the literature of this rare tumor. …”
    Get full text
    Article
  10. 3470

    Immunotherapy: An Optimal Control Theory Approach by K. Renee Fister, Jennifer Hughes Donnelly

    Published 2005-07-01
    “…We investigate mathematical models for the dynamics between tumor cells, immune-effector cells, and cytokine interleukin-2 (IL-2). …”
    Get full text
    Article
  11. 3471
  12. 3472

    Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer by Luca Mastracci, Patrizio Castagnola, Elia Bari, Francesca Ferrera, Tiziana Altosole, Sara Perteghella, Pierluigi Mauri, Rossana Rossi, Giulia Passignani, Martina Galati, Giuseppina Iliana Astone, Maddalena Mastrogiacomo, Daniela Fenoglio, Dario Di Silvestre, Maria Luisa Torre, Gilberto Filaci

    Published 2023-01-01
    “…Background The current challenge for immunotherapies is to generate effective antitumor immunity. Since tumor immune escape mechanisms do not impact pre-existing and consolidated immune responses, we tested the hypothesis of redirecting a pregenerated immunity to cancer: to recall a non-tumor antigen response against the tumor, silk fibroin nanoparticles (SFNs) have been selected as ‘Trojan-horse’ carriers, promoting the antigen uptake by the tumor cells.Methods SFNs have been loaded with either ovalbumin (OVA) or CpG oligonucleotide (CpG) as antigen or adjuvant, respectively. …”
    Get full text
    Article
  13. 3473

    Anti-PD-1 amplifies costimulation in melanoma-infiltrating Th1-like Foxp3+ regulatory T cells to alleviate local immunosuppression by Fernando Alvarez, Fan Huang, Sonia V Del Rincon, Mikhaël Attias, Tho-Alfakar Al-Aubodah, Roman Istomine, Paige McCallum, Abrahim Sleiman, Tamiko Nishimura, Yasser Riazalhosseini, Ciriaco A Piccirillo

    Published 2025-01-01
    “…Background Immune checkpoint inhibitors targeting programmed cell death protein-1 (PD-1) are the first line of treatment for many solid tumors including melanoma. PD-1 blockade enhances the effector functions of melanoma-infiltrating CD8+ T cells, leading to durable tumor remissions. …”
    Get full text
    Article
  14. 3474

    Endobronchial Infection and Bacterial Lymphadenitis by Gemella morbillorum Leading to Airway Perforation and a Bronchopleural Fistula by Kaitlin N. DePrez, John Ferguson

    Published 2024-01-01
    “…Conclusion: In cases of severe mediastinal adenopathy in a young patient, bacterial lymphadenitis should be considered in the differential diagnosis with lymphoma, germ cell tumor, granulomatosis with polyangiitis, sarcoidosis, histoplasmosis, and inflammatory myofibroblastic tumor.…”
    Get full text
    Article
  15. 3475

    Rare Cell Population Analysis in Early-Stage Breast Cancer Patients by Stefan Schreier, Prapaphan Budchart, Suparerk Borwornpinyo, Lakkana Adireklarpwong, Prakasit Chirappapha, Wannapong Triampo, Panuwat Lertsithichai

    Published 2025-01-01
    “…Sampling was conducted both before and after tumor resection. Methods: Linearity of the Rarmax platform was established using a spike-in approach. …”
    Get full text
    Article
  16. 3476

    Implantable Ultrasound‐Powered MXene/PVA Hydrogel‐Based Generator for Treatment of Glioblastoma by Xiaoping Hu, Ziyi Qiu, Yilin Yang, Ting Xu, Kai Sheng, Weicheng Lu, Jingdun Xie, Bingzhe Xu

    Published 2025-02-01
    “…In vitro and in vivo experiments confirmed the device's therapeutic effect, demonstrating a ≈92% inhibition rate in the growth of clinical tumor cells and a 73% reduction in tumor area in tumor‐bearing mice. …”
    Get full text
    Article
  17. 3477

    A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review by Tomoo Kakimoto, Mamoru Sasaki, Tatsuya Yamamoto, Arifumi Iwamaru, Kentaro Ogata, Ko Lee, Shingo Nakayama, Naoto Minematsu

    Published 2019-01-01
    “…We previously reported a case of giant cell carcinoma in the lung, in which the use of antiprogrammed death 1 (PD-1) immunotherapy resulted in substantial tumor reduction. In the present study, we describe an additional clinical course. …”
    Get full text
    Article
  18. 3478

    Giant Parotid Pleomorphic Adenoma Involving Parapharyngeal Space by Sukri Rahman, Bestari J Budiman, Yurni Yurni

    Published 2013-09-01
    “…<p>Abstrak<br />Latar belakang: Pleomorfik adenoma parotis merupakan tumor jinak kelenjar liur yang paling sering ditemukan, namun pleomorfik adenoma parotis yang sangat besar sehingga melibatkan ruang parafaring (RPF) sangat jarang. …”
    Get full text
    Article
  19. 3479

    Dual Effect of Serum Amyloid A on the Invasiveness of Glioma Cells by Franciele Hinterholz Knebel, Renata Chaves Albuquerque, Renato Ramos Massaro, Silvya Stuchi Maria-Engler, Ana Campa

    Published 2013-01-01
    “…Evidence sustains a role for the acute-phase protein serum amyloid A (SAA) in carcinogenesis and metastasis, and the protein has been suggested as a marker for tumor progression. Nevertheless, the demonstration of a direct activity of SAA on tumor cells is still incipient. …”
    Get full text
    Article
  20. 3480

    TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma by Lingyun Kuang, Yilin Pang, Quangang Fang

    Published 2024-12-01
    “…The findings from CIBERSORT analysis suggest that TMEM101’s pro-tumor effect may be due to decreasing the number of anti-tumor immune cells (M1 macrophages and resting memory CD4+ T cells) and promoting M0 macrophage infiltration in the tumor microenvironment (TME). …”
    Get full text
    Article